EP3092252
ANTIBODY TARGETING CELL SURFACE DEPOSITED COMPLEMENT PROTEIN C3D AND USE THEREOF
:
EP einkaleyfi: Þýðing ekki lögð inn:
8.1.2015:
18.9.2019:
15701442.4
:
7.1.2035
:
ANTIBODY TARGETING CELL SURFACE DEPOSITED COMPLEMENT PROTEIN C3D AND USE THEREOF
8.1.2015
18.9.2019
:
The U.S.A. as represented by the Secretary, Department of Health and Human Services:
Office of Technology Transfer National Institutes of Health 6011 Executive Boulevard, Suite 325 MSC 7660, 20892-7660, Bethesda, MD, US
:
University of Virginia Patent Foundation d/b/a University of Virginia Licensing & Ventures Group:
250 West Main Street, Suite 300, 22902, Charlottesville, VA, US
:
WIESTNER, Adrian U.:
Bethesda, Maryland, US
:
SKARZYNSKI, Martin W.:
North Bethesda, Maryland, US
:
LINDORFER, Margaret A.:
Keswick, Virginia, US
:
TAYLOR, Ronald P.:
Keswick, Virginia, US
:
RADER, Christoph:
Jupiter, Florida, US
:
VIRE, Bérengère:
Les Matelles, FR
:
201461924967 P:
8.1.2014:
US
:
US2015010620:
8.1.2015
:
C07K 16/18, C07K 16/30, A61P 35/02, C07K 14/725, C07K 14/47, A61K 39/00